Friday, Apr 11, 2025 · SEC filings
What the smart money revealed on Apr 11
316 insider filings came in. We hid 36 planned (10b5-1) sellers and 218 people whose filings were routine, like grants and tax withholding.
Tectonic Therapeutic (TECX) Director Timothy Springer bought $2.3M
141,923 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 8 checked quarters beat the typical stock 6 months later.
Cartesian Therapeutics (RNAC) Director Timothy Springer bought $1.52M
149,075 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 8 checked quarters beat the typical stock 6 months later.
Delta Air Lines (DAL) Director David Taylor bought $392K
10,000 shares on the open market. Not a grant or an option exercise.
Delta Air Lines (DAL) Director Greg Creed bought $209K
5,000 shares on the open market. Not a grant or an option exercise.
FedEx (FDX) Executive Chairman Frederick Smith sold $25.1M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 14.29M shares directly.
Compass Therapeutics (CMPX) Director Carl Gordon sold $5.68M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Simply Good Foods (SMPL) SVP and General Manager Stuart Heflin Jr. sold $186K
Not marked as a planned 10b5-1 sale. Sold 28% of the shares they held directly. Still holds 12,839 shares.
Show 21 more real buys
Show 14 more real sales
13F season
Holdings as of Mar 31, 2025 are due May 15
92 funds have filed so far. 80 filed for the quarter before.
Biggest real insider buys, Apr 5–11
Open-market buys by officers and directors, filed in the 7 days up to Apr 11.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.